Niklas Rindtorff und Johannes Betge Person-Info 

( Ich bin Niklas Rindtorff)
(1 - 5 von 14
)

Enabling Technologies- Multiparametric P...Sched

slas2019advanced3dhumanmodelsand.sched.com
Finally, by viability classification, we show heterogeneous susceptibilities of PDOs to clinical anticancer drugs. Authors: Johannes Betge, Niklas Rindtorff, ... Finally, by viability classification, we show heterogeneous susceptibilities of PDOs to clinical anticancer drugs. Authors: Johannes Betge, Niklas Rindtorff, ...
+1